Hualan Biological shareholders approve director election, trademark use

Hualan Biological Engineering Co., Ltd. held its third extraordinary general meeting in 2025 on November 17, with 862 shareholders and proxies representing 941,046,244 shares, or 51.4949% of total voting shares. All proposals were passed without objection or cancellation, affirming shareholder consensus on the agenda items.

The first proposal, concerning the election of independent directors for the ninth board of directors, received overwhelming approval with 938,782,749 votes in favor (99.7595%). Only 1,669,097 shares opposed, and 594,398 shares abstained. Similarly, the second proposal, authorizing related parties to use the company’s registered trademarks, also passed with strong support. It garnered 96,110,410 votes in favor (97.1536%), with 2,306,397 votes against and 509,398 shares abstaining.

The meeting procedures, including quorum and voting, were confirmed by legal counsel to comply with relevant laws, regulations, and the company's articles of association, ensuring the validity of all resolutions passed.